The synthesis of melatonin, a vital hormone that regulates sleep-wake cycles, often relies on specific chemical precursors. Among these, 5-Methoxytryptamine (CAS 608-07-1) plays a pivotal role as a key intermediate. For pharmaceutical companies and research institutions involved in melatonin production, sourcing this compound with utmost purity and reliability is a critical operational requirement. Understanding its properties and the supply chain is therefore essential for efficient manufacturing.

5-Methoxytryptamine, with its chemical formula C11H14N2O, is a tryptamine derivative that undergoes specific biochemical transformations to yield melatonin. Its critical function in this pathway means that even minor impurities can significantly impact the final product's quality and efficacy. As a leading China-based manufacturer, we specialize in producing 5-Methoxytryptamine with a guaranteed purity of 99.00% minimum, ensuring it meets the stringent requirements of pharmaceutical synthesis. For those looking to buy this intermediate, our consistent quality is a major advantage.

We are recognized as a premier supplier of 5-Methoxytryptamine, offering competitive price points to support the scaling of melatonin production. Our efficient manufacturing processes and robust supply chain management allow us to cater to both research quantities and bulk industrial orders. When you need to purchase this vital compound, partnering with a trustworthy Chinese factory like ours can provide significant cost benefits and ensure supply chain stability. We are committed to providing a reliable source for this essential melatonin precursor.

To facilitate your melatonin synthesis projects, we encourage you to connect with us for a detailed quote and to discuss your specific needs. Whether you require samples for validation or large-scale orders, our team is equipped to provide excellent service and technical support. As a dedicated manufacturer and supplier, we aim to be your go-to source for high-quality 5-Methoxytryptamine, supporting innovation in the pharmaceutical sector.